Synopsys operates as a dominant player in the consolidated EDA oligopoly. Secular tailwinds from increasing semiconductor complexity ensure mission-critical reliance on its software. However, a massive recent acquisition significantly boosts scale but temporarily pressures balance sheet health and operating margins. Fair value range: low $206, high $386, with mid-point at $294.
Stock analysis
Synopsys Inc.SNPS Synopsys Inc. fair value $294–$386
Englische Quelle wird angezeigt, während wir übersetzen
Dieser Bericht wurde noch nicht übersetzt. Aktualisieren Sie in ein paar Minuten, sobald die Übersetzungswarteschlange aufgeholt hat.
§1 Zusammenfassung
Current price of $516.48 ignores the fundamental risk introduced by $13.4B of fresh M&A debt.
Intrinsic models assign a mid-point of $293.61, heavily penalizing fading ROIC and integration risks.
A wide model spread exists, but even optimistic forward earnings models top out at $453.
The market is pricing in flawless execution and rapid deleveraging, offering zero margin of safety.
Fair value
$294
Margin of safety
-75.9%
Confidence
78/100
Moat
9/10
Educational analysis only — not financial advice. Always do your own due diligence.
$516.48Price
FV $293.6
High $386.33
Synopsys operates as a dominant player in the consolidated EDA oligopoly. Secular tailwinds from increasing semiconductor complexity ensure mission-critical reliance on its software. However, a massive recent acquisition significantly boosts scale but temporarily pressures balance sheet health and operating margins.
High Switching Costs
High Switching Costs
Intangible Assets
Intangible Assets
Cycle upside
Accelerating AI-driven chip designs and reshoring of fabs increase EDA software demand.
§2 Bärenszenario
Under a recessionary stress test, top-line growth stalls to low single digits while the heavy fixed-cost base and massive $13.4B debt load decimate free cash flow. This combination leaves management unable to deleverage organically, forcing highly dilutive capital raises.
Wie diese These scheitern kann
M&A Integration Failure
· Medium
The recent transformative acquisition faces severe cultural and technical friction, causing delayed synergies and margin compression.
FV impact
-30%
Prolonged Semiconductor Cyclical Downturn
· Low
A severe pullback in global fab and R&D spending directly hits EDA tool renewals and seat expansions.
FV impact
-25%
Debt Servicing Crisis
· Low
The massive $13.4B debt load restricts operational flexibility amid rising interest rates, forcing dilutive equity raises or asset firesales.
FV impact
-40%
Frühwarnsignale zur Überwachung
Kennzahl
Aktuell
Auslöseschwelle
Operating margins fail to revert to the 25% historical baseline.
Monitor
Deterioration versus the report thesis
Net debt issuance accelerates instead of declining post-M&A.
Monitor
Deterioration versus the report thesis
Loss of market share to primary competitor Cadence.
Monitor
Deterioration versus the report thesis
Semiconductor capital expenditure guidance sharply revised downward.
Monitor
Deterioration versus the report thesis
Key engineering and executive talent departures post-acquisition.
Monitor
Deterioration versus the report thesis
§3 Finanzielle Historie
Gewinn- und Verlustrechnung — letzte sechs Perioden
Based on our latest analysis, SNPS looks meaningfully overvalued. The current price is $516 versus a composite fair-value midpoint of $294 (range $206–$386), which implies roughly 43.1% downside to the midpoint.
Our composite fair-value range for SNPS is $206–$386, with a midpoint of $294. The range is triangulated across multiple valuation models (discounted earnings, forward earnings scenarios, peer multiples, and where applicable owner earnings or reverse DCF) and weighted by reliability for Synopsys Inc.'s archetype.
Our current rating for SNPS is Sell with a confidence score of 78/100. Sell. The current $516 price implies flawless execution of the recent mega-acquisition, ignoring the severely altered balance sheet and noisy trailing financials. This is research for educational purposes, not personalized investment advice.
The top risks our latest report flags for Synopsys Inc. are: M&A Integration Failure; Prolonged Semiconductor Cyclical Downturn; Debt Servicing Crisis. The single biggest risk is M&A Integration Failure: The recent transformative acquisition faces severe cultural and technical friction, causing delayed synergies and margin compression.
Our current rating for SNPS is Sell, issued with a confidence score of 78/100 and a moat score of 9/10. The rating reflects the composite fair-value range ($206–$386) versus the current price of $516.
Synopsys Inc. is classified as a mature compounder stock. Archetype determines how every downstream parameter — discount rate, terminal growth, deceleration curve, terminal multiple, scenario probability weights, scorecard weights, and which valuation models are prioritized — is calibrated for SNPS.
